selected publications
- Altered distribution of tissue galectins correlates with mucosal dysregulation in SIV infection. Journal of immunology (Baltimore, Md. : 1950). 2025 Academic Article GET IT
- Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People Living with HIV. The Journal of infectious diseases. 2025 Academic Article GET IT
-
Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid model.
Journal of neuroinflammation.
2025
Academic Article
GET IT
Times cited: 2 - Plasma anti-CD4 IgG levels are associated with poor immune recovery in people with HIV initiating antiretroviral therapy. AIDS (London, England). 2025 Academic Article GET IT
-
Alterations in circulating immunoregulatory proteins discriminate poor CD4 T lymphocyte trajectories in people with HIV on suppressive antiretroviral therapy.
mBio.
2024
Academic Article
GET IT
Times cited: 1 -
Dendritic Cells Pulsed with HAM/TSP Exosomes Sensitize CD4 T Cells to Enhance HTLV-1 Infection, Induce Helper T-Cell Polarization, and Decrease Cytotoxic T-Cell Response.
Viruses.
2024
Academic Article
GET IT
Times cited: 1 -
Machine learning models based on fluid immunoproteins that predict non-AIDS adverse events in people with HIV.
iScience.
2024
Academic Article
GET IT
Times cited: 3 -
Plasma galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.
AIDS (London, England).
2024
Academic Article
GET IT
Times cited: 3 -
The latent HIV reservoir: current advances in genetic sequencing approaches.
mBio.
2023
Review
GET IT
Times cited: 10 -
Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation.
Journal of extracellular biology.
2023
Academic Article
GET IT
Times cited: 4 -
Decrypting biological hallmarks of aging in people with HIV.
Current opinion in HIV and AIDS.
2023
Review
GET IT
Times cited: 6 -
Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment.
AIDS (London, England).
2023
Academic Article
GET IT
Times cited: 9 -
Multiplex Analysis of Cytokines and Chemokines in Persons Aging With or Without HIV.
AIDS research and human retroviruses.
2023
Academic Article
GET IT
Times cited: 1 -
Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states.
Journal of neurovirology.
2023
Academic Article
GET IT
Times cited: 157 -
Increased transmigration of intermediate monocytes associated with atherosclerotic burden in people with HIV on antiretroviral therapy.
AIDS (London, England).
2023
Letter
GET IT
Times cited: 2 - Multiplex analysis of cytokines and chemokines in persons aging with or without HIV. 2023 GET IT
-
Brain volumetrics differ by Fiebig stage in acute HIV infection.
AIDS (London, England).
2023
Academic Article
GET IT
Times cited: 4 -
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice.
AIDS (London, England).
2022
Academic Article
GET IT
Times cited: 6 -
Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection.
Frontiers in immunology.
2022
Academic Article
GET IT
Times cited: 5 -
Mucosal-homing natural killer cells are associated with aging in persons living with HIV.
Cell reports. Medicine.
2022
Academic Article
GET IT
Times cited: 7 -
Individual Differences in CD4/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV Infection.
Psychosomatic medicine.
2022
Academic Article
GET IT
Times cited: 11 -
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies.
Frontiers in immunology.
2022
Review
GET IT
Times cited: 20 -
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy.
Open forum infectious diseases.
2022
Academic Article
GET IT
Times cited: 5 - Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam. AIDS research and human retroviruses. 2022 Academic Article GET IT
-
Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
AIDS (London, England).
2021
Academic Article
GET IT
Times cited: 12 -
Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research.
mBio.
2021
Review
GET IT
Times cited: 20 -
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID.
Allergy.
2021
Academic Article
GET IT
Times cited: 44 -
Neurocognitive Trajectories After 72 Weeks of First-Line Anti-retroviral Therapy in Vietnamese Adults With HIV-HCV Co-infection.
Frontiers in neurology.
2021
Academic Article
GET IT
Times cited: 2 -
Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
Journal of leukocyte biology.
2021
Academic Article
GET IT
Times cited: 97 -
Hiding in plain sight - platelets, the silent carriers of HIV-1.
Platelets.
2020
Academic Article
GET IT
Times cited: 4 -
Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide.
Frontiers in public health.
2020
Academic Article
GET IT
Times cited: 27 -
Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy.
Frontiers in immunology.
2020
Academic Article
GET IT
Times cited: 16 -
Plasma inflammatory biomarkers link to diffusion tensor imaging metrics in virally suppressed HIV-infected individuals.
AIDS (London, England).
2020
Academic Article
GET IT
Times cited: 30 -
Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.
Frontiers in immunology.
2019
Academic Article
GET IT
Times cited: 2 -
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models.
Frontiers in oncology.
2019
Academic Article
GET IT
Times cited: 10 -
Geriatric Syndromes in Older Adults Living with HIV and Cognitive Impairment.
Journal of the American Geriatrics Society.
2019
Academic Article
GET IT
Times cited: 32 -
Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion.
Oncoimmunology.
2019
Academic Article
GET IT
Times cited: 21 -
Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling.
Frontiers in immunology.
2019
Academic Article
GET IT
Times cited: 34 -
Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
Journal of neurovirology.
2018
Academic Article
GET IT
Times cited: 30 -
Role of Natural Killer Cells in HIV-Associated Malignancies.
Frontiers in immunology.
2017
Review
GET IT
Times cited: 9